semaglutide to dulaglutide conversion Sleeve-to-bypass vs. sleeve-with-adjuvant GLP-1 receptor agonists: an academic multicenter retrospective study | Surgical Endoscopy transitioning from semaglutide to tirzepatide

Key Insight: GLP-1 therapies arent just about weight loss anymore

In-vitro skin diffusion studies demonstrated a 5-fold increase in glutathione deposition compared to the free drug control

Animal studies have revealed significant associations between these metabolites and blood pressure regulation

The six-week mark is your decision point

In the STEP 1 trial extension, participants who stopped semaglutide after 68 weeks regained roughly two-thirds of their prior weight loss within a year, and related cardiometabolic improvements moved back toward baseline

When combined with retatrutide, people report nausea from alcohol consumption at levels that previously caused no issues